ProShares Ultra Nasdaq Biotechnology (BIB)

Add to Watchlists
Create an Alert
43.79 +0.00  +0.00% NASDAQ May 2, 21:55 Delayed 2m USD
View Full Chart
BIB Price Chart

BIB Key Stats

Expense Ratio (1-15-16) 0.95%
Assets Under Management (5-2-16) 455.70M
30-Day Average Volume (4-29-16) 998988.9
Net Asset Value (5-2-16) 43.82
Discount or Premium to NAV (5-2-16) -0.07%
Turnover Ratio (5-31-15) 41.00%

BIB Asset Allocation

Type % Net % Long % Short
Cash -97.22% 21.82% 119.0%
Stock 78.18% 78.18% 0.00%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.00% 0.00% 0.00%
Other 119.0% 121.6% 2.54%
As of March 31, 2016
View More Holdings

BIB Top 10 Holdings

Symbol Name % Weight Price % Chg
-- Nasdaq Biotechnology Index Swap Societe Generale 46.14% -- --
-- Ishares Biotech (Ibb) Swap Deutsche Bank Ag 20.06% -- --
-- Nasdaq Biotechnology Index Swap Bank Of America Na 17.85% -- --
-- Nasdaq Biotechnology Index Swap Credit Suisse International 16.30% -- --
AMGN Amgen Inc 6.45% 158.94 -0.03%
GILD Gilead Sciences Inc 6.44% 89.01 +0.01%
BIIB Biogen Inc 6.14% 273.68 -0.00%
CELG Celgene Corp 6.07% 104.96 -0.01%
REGN Regeneron Pharmaceuticals Inc 5.52% 384.65 +0.03%
-- Nasdaq Biotechnology Index Swap Deutsche Bank Ag 5.48% -- --
As of March 31, 2016
Advertisement

BIB Basic Info

Style
Equity Style Large Cap/Growth
Broad Asset Class Alternative
Broad Category Alternative
Category Name Trading-Leveraged Equity
Prospectus Objective Specialty - Technology
Fund Owner Firm Name ProShares
Benchmark Index
NASDAQ Biotechnology TR USD
200.0%

BIB Manager Info

Name Tenure
Charles Lowery 2.50 yrs
Michael Neches 2.50 yrs

BIB Risk Info

Beta 2.189
Max Drawdown (All) 65.24%
Historical Sharpe (10Y) --
Historical Sortino (All) 1.370
30-Day Rolling Volatility 63.58%
Daily Value at Risk (VaR) 1% (All) 8.46%
Monthly Value at Risk (VaR) 1% (All) 33.80%

BIB Performance

  Returns Total Returns
1M 8.02% 8.02%
3M -1.86% -1.86%
6M -37.25% -37.25%
1Y -46.04% -46.04%
3Y 87.35% 87.35%
5Y 338.0% 338.0%
As of May 2, 2016

BIB Net Flows

1M -4.222M
3M -13.82M
6M -56.70M
YTD -1.222M
1Y -59.32M
3Y 381.32M
5Y 431.99M
As of April 30, 2016

BIB Comparables

Edit

BIB Attributes

Key Dates
Inception Date 4/6/2010
Last Annual Report Date 5/31/2015
Last Prospectus Date 1/15/2016
Attributes
Exchange Traded Share Yes
Exchange Traded Note No
Enhanced Index Fund No
Index Fund Yes
Inverse Fund No
Leveraged Fund Yes
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No

BIB Excel Add-In Codes

  • Name: =YCI("BIB","name")
  • Broad Asset Class: =YCI("BIB", "broad_asset_class")
  • Broad Category: =YCI("BIB", "broad_category_group")
  • Prospectus Objective: =YCI("BIB", "prospectus_objective")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.